Canadian Lawyer: Kristin Wall speaks about Canada's unique pharmaceutical IP protection regime.

COVID pandemic highlighted Canada's unique pharmaceutical IP protection regime | Canadian Lawyer

Following the publication of Norton Rose Fulbright’s 2022 Guide to Canada’s Pharmaceutical Intellectual Property Regime, Toronto partner, lawyer and trademark agent Kristin Wall spoke with Canadian Lawyer about the impact of the COVID-19 pandemic on Canada’s pharmaceutical industry, from an IP stand point. 

“The COVID-19 pandemic held a bright side and a dark side for Canada’s pharmaceutical industry. On the negative end, the sector faced the same supply chain issues many companies have experienced. But the crisis also showed its innovative potential.”